VALTOCO(®) (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity

Valtoco(®) is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age and older. Although IV and rectal diazepam are already used to treat seizure clusters, Valt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Int
Main Authors: Cornett, Elyse M., Amarasinghe, Sam N., Angelette, Alexis, Abubakar, Tunde, Kaye, Adam M., Kaye, Alan David, Neuchat, Elisa E., Urits, Ivan, Viswanath, Omar
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931041/
https://ncbi.nlm.nih.gov/pubmed/33670456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/neurolint13010007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados